Download up to 50 records using a credit card to purchase your current search results.
Purchase your current search resultsIf your search contains more than 50 records, you will receive only the first 50 based on the sorting chosen at the time of purchase. Downloads will contain all fields shown in the individual records, not only those visible on the search results page. If your search is 50 records or higher, a subscription might be a better option.
If your search contains fewer than 50 records, the balance cannot be used for a separate search.
Once you subscribe, you will be able to download your current search results. Downloads will contain all fields shown in the individual records, not only those visible on the search results page.
If the number of records in your search results exceeds the limit of your subscription tier, your download will include the maximum number based on the sorting chosen at the time of the download.
Top 5 Jurisdictions | Penalty Total (USD) | Number of Records |
---|---|---|
United States | $8,452,667,995 | 43 |
European Commission | $606,513,940 | 5 |
Israel | $22,073,400 | 1 |
India | $1,337,070 | 1 |
Top 5 Offense Groups | Penalty Total (USD) | Number of Records |
---|---|---|
healthcare-related offenses | $5,434,929,633 | 12 |
competition-related offenses | $2,691,914,688 | 13 |
government-contracting-related offenses | $825,649,214 | 17 |
consumer-protection-related offenses | $126,407,000 | 2 |
environment-related offenses | $3,686,870 | 5 |
Click on the company or penalty amount for more information on each case.
Company | Current Parent Industry | Offense Category | Year | Jurisdiction | Penalty Amount (USD) |
---|---|---|---|---|---|
Teva Pharmaceuticals | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | United States | $4,250,000,000 |
Cephalon, Inc. | pharmaceuticals | anti-competitive practices | 2015 | United States | $1,200,000,000 |
Teva | pharmaceuticals | anti-competitive practices | 2024 | European Commission | $499,968,828 |
Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. | pharmaceuticals | government contracting fraud | 2024 | United States | $450,000,000 |
Teva Pharmaceuticals, Ltd. | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | United States | $313,343,793 |
Teva Pharmaceutical Industries Ltd | pharmaceuticals | kickbacks and bribery | 2016 | United States | $283,177,348 |
Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | United States | $278,826,499 |
Teva Pharmaceuticals USA, Inc. | pharmaceuticals | anti-competitive practices | 2023 | United States | $275,000,000 |
Teva Pharmaceutical Industries Limited | pharmaceuticals | kickbacks and bribery | 2016 | United States | $236,000,000 |
Teva Pharmaceutical Industries Ltd. | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | United States | $225,000,000 |
Teva Pharmaceuticals Inc. | pharmaceuticals | government contracting fraud | 2010 | United States | $169,000,000 |
Cephalon | pharmaceuticals | consumer protection violation | 2016 | United States | $125,000,000 |
Teva Pharmaceuticals | pharmaceuticals | controlled substances violation | 2019 | United States | $85,000,000 |
Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | United States | $83,000,000 |
Teva Pharmaceuticals, Inc. | pharmaceuticals | off-label or unapproved promotion of medical products | 2023 | United States | $71,477,474 |
Teva | pharmaceuticals | off-label or unapproved promotion of medical products | 2024 | United States | $70,281,867 |
Watson Pharmaceuticals | pharmaceuticals | government contracting fraud | 2011 | United States | $70,000,000 |
Teva Pharmaceutical Industries Ltd. | pharmaceuticals | anti-competitive practices | 2019 | United States | $69,000,000 |
Cephalon Inc. | pharmaceuticals | anti-competitive practices | 2020 | European Commission | $36,310,250 |
Teva Pharmaceutical | pharmaceuticals | anti-competitive practices | 2020 | European Commission | $35,715,000 |
Watson, Inc. | pharmaceuticals | government contracting fraud | 2018 | United States | $33,408,547 |
Actavis Mid-Atlantic, LLC and Actavis Elizabeth, LLC | pharmaceuticals | government contracting fraud | 2011 | United States | $29,230,000 |
Teva Pharmaceuticals USA Inc. and IVAX LLC | pharmaceuticals | government contracting fraud | 2014 | United States | $27,600,000 |
Teva Parmaceuticals | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | United States | $27,000,000 |
Teva Pharmaceuticals | pharmaceuticals | kickbacks and bribery | 2018 | Israel | $22,073,400 |
Teva UK Limited | pharmaceuticals | anti-competitive practices | 2014 | European Commission | $21,180,294 |
Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | United States | $21,000,000 |
Arrow Group | pharmaceuticals | anti-competitive practices | 2013 | European Commission | $13,339,568 |
Teva Pharmaceuticals USA Inc. | pharmaceuticals | kickbacks and bribery | 2014 | United States | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Penalty totals are adjusted to avoid double-counting. $12,100,000 |
Alpharma USPD, Inc. and Purepac Pharmaceutical Co. | pharmaceuticals | government contracting fraud | 2011 | United States | $10,200,000 |
Teva Pharmaceuticals USA Inc., IVAX Corporation, IVAX Pharmaceuticals Inc., Sicor Inc., Barr Laboratories Inc. and Duramed Pharmaceuticals Inc. | pharmaceuticals | government contracting fraud | 2010 | United States | $10,000,000 |
Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2022 | United States | $8,200,000 |
Cephalon Inc. | pharmaceuticals | government contracting fraud | 2015 | United States | $7,500,000 |
Cephalon, Inc. | pharmaceuticals | government contracting fraud | 2015 | United States | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Penalty totals are adjusted to avoid double-counting. $7,500,000 |
Teva Pharmaceuticals USA, Inc. et al. | pharmaceuticals | government contracting fraud | 2010 | United States | $6,500,000 |
Actavis Elizabeth LLC | pharmaceuticals | government contracting fraud | 2010 | United States | $3,600,000 |
Teva Pharmaceuticals USA | pharmaceuticals | environmental violation | 2013 | United States | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Penalty totals are adjusted to avoid double-counting. $2,402,793 |
Watson Pharmaceuticals, Inc. | pharmaceuticals | government contracting fraud | 2010 | United States | $2,400,000 |
Teva Pharmaceuticals USA Inc. | pharmaceuticals | air pollution violation | 2013 | United States | $2,250,000 |
TEVA PHARMACEUTICALS USA INC | pharmaceuticals | environmental violation | 2013 | United States | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Penalty totals are adjusted to avoid double-counting. $2,250,000 |
Alpharma USPD, Inc., | pharmaceuticals | government contracting fraud | 2011 | United States | $2,010,667 |
Teva Pharmaceuticals USA, Inc., Ivax Corp., Ivax Pharmaceuticals, Inc., and Barr Laboratories, Inc. | pharmaceuticals | government contracting fraud | 2010 | United States | $1,900,000 |
Anda | pharmaceuticals | controlled substances violation | 2016 | United States | $1,800,000 |
Watson Pharmaceuticals Inc. and Watson Pharma Inc. | pharmaceuticals | government contracting fraud | 2012 | United States | $1,700,000 |
Teva Pharmaceuticals, Inc. | pharmaceuticals | consumer protection violation | 2023 | United States | $1,407,000 |
Teva API Ltd. | pharmaceuticals | land use violation | 2021 | India | $1,337,070 |
Alpharma USPD, Inc. | pharmaceuticals | government contracting fraud | 2010 | United States | $600,000 |
Teva Pharmaceuticals USA, Inc. | pharmaceuticals | anti-competitive practices | 2014 | United States | $150,000 |
ACTAVIS ELIZABETH LLC | pharmaceuticals | air pollution violation | 2016 | United States | $99,800 |
TEVA PHARMACEUTICAL USA, INC. | pharmaceuticals | workplace safety or health violation | 2016 | United States | $5,000 |